pRIFLE Pediatric AKI

ورودی‌های بالینی بیمار

حداقل ۰ — حداکثر ۱۰۰ • واحد: %

حداقل ۱ — حداکثر ۲۰۰ • واحد: mL/min/1.73m²

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
prifle class
—class
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • No AKI0–0
  • Risk1–1
  • Injury2–2
  • Failure3–3
Direct Clinical Answer

The pRIFLE Pediatric AKI calculates calculating weight-based pediatric dosing and evaluating age-specific physiological parameters. Key inputs include egfr decrease pct. Scores guide titrating weight-adjusted medication dosing, monitoring developmental safety, and evaluating treatment response. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

pRIFLE pediatric acute kidney injury classification (Akcan-Arikan 2007): Risk (eGFR ↓≥25% or UO <0.5 mL/kg/h × 8 h), Injury (eGFR ↓≥50% or UO <0.5 × 16 h), Failure (eGFR ↓≥75% or eGFR <35 or UO <0.3 × 24 h or anuria × 12 h), Loss (persistent failure >4 weeks), End-stage (>3 months). Class = worst of eGFR and urine-output criteria.

Clinical Indication

The pRIFLE Pediatric AKI is indicated for bedside clinical practice to support pRIFLE pediatric acute kidney injury classification (Akcan-Arikan 2007): Risk (eGFR ↓≥25% or UO <0.5 mL/kg/h × 8 h), Injury (eGFR ↓≥50% or UO <0.5 × 16 h), Failure (eGFR ↓≥75% or eGFR <35 or UO <0.3 × 24 h or anuria × 12 h), Loss (persistent failure >4 weeks), End-stage (>3 months). Class = worst of eGFR and urine-output criteria.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Neonates, infants, children, and adolescents from birth up to 18 years of age. Clinical application is indicated across Pediatric emergency departments, pediatric inpatient wards, PICU, and pediatric primary care.

Limitations & Contraindications

Adult scoring thresholds and pharmacological formulas must never be applied to pediatric patients.

Clinical Pearls & Action Plan

Accurate weight-based dosing and age-stratified physiological vital sign reference ranges are foundational in pediatric clinical practice.

Formula & Variables:

Class = worst(eGFR criterion, UO criterion)

Input Parameters

NameTypeRequiredDescription
egfr_decrease_pctfloatYeseGFR percent decrease from baseline(%)
egfr_currentfloatNoCurrent eGFR (for the <35 Failure rule)(mL/min/1.73m²)
uo_categorystringNoWorst urine-output category observed
persistencestringNoPersistent failure duration

Score Interpretation & Guidance

RangeStageDescription
0–0No AKINo AKI
1–1RiskRisk
2–2InjuryInjury
3–3FailureFailure
4–4LossLoss
5–5End-stageEnd-stage

Evidence-Based References (EBM)

  • Akcan-Arikan A, Zappitelli M, Loftis LL, et al. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int. 2007;71(10):1028-1035.

Related calculators